• SENSEX
    NIFTY 50
Retail

P&G acquires Merck's consumer health business for about $4.21 billion

Updated : April 19, 2018 12:34 PM IST

Morgan Stanley analyst Vincent Meunier said the price still implied a valuation of 4.7 times sales and around 19 times operating profit (EBITDA) for the business, at the high end of recent deals seen in the sector.
Shares in Merck rose 2.9% to the top of the German blue-chip DAX index in pre-market trade at brokerage Lang & Schwarz.
P&G also announced it would also terminate its consumer care joint venture with Teva Pharmaceutical Industries, PGT Healthcare, on July 1.
P&G acquires Merck's consumer health business for about $4.21 billion

You May Also Like

Live TV
Advertisement